Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statements of Stockholders??? Equity

v3.21.1
Consolidated Statements of Stockholders’ Equity - USD ($)
$ in Thousands
Total
As previously reported
Retroactive application of recapitalization
Common Shares
Common Shares
As previously reported
Common Shares
Retroactive application of recapitalization
Preferred Shares
Preferred Shares
As previously reported
Preferred Shares
Retroactive application of recapitalization
Additional Paid-in Capital
Additional Paid-in Capital
As previously reported
Additional Paid-in Capital
Retroactive application of recapitalization
Retained Earnings/(Deficit)
Retained Earnings/(Deficit)
As previously reported
Attributable to Non- controlling Interest
Attributable to Non- controlling Interest
As previously reported
Beginning balance (in shares) at Dec. 31, 2019       8,304,030 19,266,609 (10,962,579) 0 5,988,957 (5,988,957)              
Beginning balance at Dec. 31, 2019 $ 50,193 $ 50,193 $ 0 $ 0 $ 2 $ (2) $ 0 $ 1 $ (1) $ 77,431 $ 77,428 $ 3 $ (31,933) $ (31,933) $ 4,695 $ 4,695
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                
Stock-based compensation expenses 416                 416            
Net loss (10,186)                       (9,282)   (904)  
Ending balance (in shares) at Mar. 31, 2020       8,304,030     0                  
Ending balance at Mar. 31, 2020 40,423     $ 0     $ 0     77,847     (41,215)   3,791  
Beginning balance (in shares) at Dec. 31, 2019       8,304,030 19,266,609 (10,962,579) 0 5,988,957 (5,988,957)              
Beginning balance at Dec. 31, 2019 50,193 $ 50,193 $ 0 $ 0 $ 2 $ (2) $ 0 $ 1 $ (1) 77,431 $ 77,428 $ 3 (31,933) $ (31,933) 4,695 $ 4,695
Ending balance (in shares) at Dec. 31, 2020       24,883,024     0                  
Ending balance at Dec. 31, 2020 95,250     $ 0     $ 0     164,264     (69,014)   0  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                
Stock-based compensation expenses $ 1,550                 1,550            
Issuance of common shares upon vesting of RSUs (in shares) 7,713                              
Founders earnout shares vested (in shares)       570,212                        
Net loss $ (13,765)                       (13,765)      
Common shares issued for exercise of warrants (in shares)       122,639                        
Common shares issued for exercise of warrants 1,410                 1,410            
Ending balance (in shares) at Mar. 31, 2021       25,583,588     0                  
Ending balance at Mar. 31, 2021 $ 84,445     $ 0     $ 0     $ 167,224     $ (82,779)   $ 0